MedinGlobal

Edit Template

CYCLOXAN 1GM

In Stock

CYCLOXAN 1GM contains Cyclophosphamide 1000mg and is listed as a prescription anticancer medicine marketed by Biochem Pharmaceutical Industries. It belongs to the alkylating agent class and may be prescribed for selected cancers and other specialist indications. Its active ingredient damages the DNA of rapidly dividing cells. Treatment requires oncology supervision, with blood counts, infection risk, bladder toxicity and fertility risks requiring appropriate monitoring.

Medinglobal provides medicine information and enquiry coordination. It does not manufacture, sell or dispense medicines directly. Availability and any subsequent supply are subject to verification by an appropriately authorised independent provider and applicable regulations.

CYCLOXAN 1GM – Composition, Uses and Medicine Enquiries

Product Overview

CYCLOXAN 1GM is listed as a prescription product containing Cyclophosphamide 1000mg, marketed in the source catalogue by Biochem Pharmaceutical Industries.

It belongs to the anticancer; alkylating agent class and may be prescribed for selected cancers and other specialist indications.

Its active ingredient damages the DNA of rapidly dividing cells.

Treatment suitability depends on the confirmed diagnosis, previous treatment, organ function and other medicines. The benefit-risk balance, approved use and monitoring plan must be determined by the treating specialist.

Blood counts, infection risk, bladder toxicity and fertility risks require monitoring.

Composition and Strength

The supplied product information identifies the following composition:

Active Ingredient Strength
Cyclophosphamide 1000mg

Product Name: CYCLOXAN 1GM

Generic Name: Cyclophosphamide

Brand Name: CYCLOXAN 1GM

Strength: 1000mg

Listed Marketer: Biochem Pharmaceutical Industries

The composition and strength should be verified against the original manufacturer-labelled packaging before publication or any medicine enquiry.

Therapeutic Category and Indication

CYCLOXAN 1GM belongs to the anticancer category and is classified as an alkylating agent.

It may be prescribed for selected cancers and other specialist indications.

Cyclophosphamide damages the DNA of rapidly dividing cells.

Treatment choice depends on the confirmed diagnosis, previous treatment, organ function and other medicines. The benefit-risk balance, approved use and monitoring plan must be determined by the treating specialist.

Blood counts, infection risk, bladder toxicity and fertility risks require monitoring.

Administration Information

The supplied product information identifies intravenous infusion by oncology professionals according to an approved protocol.

Administration should follow the treating clinician’s instructions and the approved product label.

Patients should not independently adjust the dose, skip safety monitoring or switch formulations without medical advice.

The exact dosage form and administration schedule must be verified against the approved product information.

Product Presentation and Availability

The product enquiry can be made using the following details:

  • Product Name: CYCLOXAN 1GM
  • Generic Name: Cyclophosphamide
  • Strength: 1000mg
  • Company Name: Biochem Pharmaceutical Industries
  • Therapeutic Category: Anticancer
  • Medicine Class: Alkylating Agent
  • Indication: Selected cancers and other specialist indications
  • Administration: Intravenous infusion by oncology professionals according to protocol

The exact dosage form, pack size, batch, storage, expiry and product-specific presentation require verification from original manufacturer packaging and an authorised provider.

Product details and supply eligibility may vary by country. A product listing does not confirm current stock or availability.

Prescription and Patient Safety

CYCLOXAN 1GM is listed as a prescription anticancer medicine and requires oncology supervision.

Treatment suitability, contraindications, interactions and monitoring requirements must be evaluated by a qualified oncology specialist.

Blood counts, infection risk, bladder toxicity and fertility risks require monitoring.

Patients should follow the approved product label and the treating oncology team’s instructions. The medicine should only be administered according to an approved clinical protocol.

Medicine Enquiry Coordination Through Medinglobal

Medinglobal is a healthcare coordination platform. It can receive medicine information requests and, where legally permissible, connect patients or institutions with appropriately authorised independent pharmaceutical providers.

Medinglobal does not itself sell, dispense, manufacture or export medicines.

Product availability, lawful supply, prescription validation, commercial terms and destination requirements must be verified by the independent provider. Submitting an enquiry does not guarantee fulfilment.

How to Submit a CYCLOXAN 1GM Enquiry

To help identify the requested product, include the following details:

  1. Product name: CYCLOXAN 1GM.
  2. Generic name: Cyclophosphamide.
  3. Required strength: 1000mg.
  4. Required formulation and quantity.
  5. Destination country.
  6. Valid prescription or institutional documents, where required.

Medinglobal may coordinate an introduction to a suitably authorised provider. The provider independently verifies product details, regulatory eligibility and any transaction.

Frequently Asked Questions

What is CYCLOXAN 1GM used for?

CYCLOXAN 1GM is associated with selected cancers and other specialist indications. The treating prescriber confirms the approved use.

What is the composition of CYCLOXAN 1GM?

The supplied catalogue lists Cyclophosphamide 1000mg as its active ingredient. The composition should be verified against the original product packaging.

How is CYCLOXAN 1GM administered?

The supplied information identifies intravenous infusion by oncology professionals according to an approved protocol.

Which company is listed for CYCLOXAN 1GM?

Biochem Pharmaceutical Industries is listed as the marketer in the supplied product information.

Does CYCLOXAN 1GM require medical supervision?

Yes. It requires oncology supervision, with monitoring of blood counts, infection risk, bladder toxicity and fertility risks.

Can Medinglobal supply CYCLOXAN 1GM directly?

No. Medinglobal coordinates medicine enquiries with independent authorised providers where legally permissible.

Product Name

Generic Name

Brand Name

Composition

Strength

Therapeutic Category

Medicine Class

Indication

Dosage Form

Route of Administration

Reviews

There are no reviews yet.

Be the first to review “CYCLOXAN 1GM”

Your email address will not be published. Required fields are marked *

Pharmaceutical Disclaimer

Medinglobal Platform does not sell, dispense, manufacture or prescribe medicines. Pharmaceutical information on this page is provided solely for general information, product identification and enquiry coordination. Product listing is not medical advice, a recommendation or an offer for sale by Teji Radiance or the Medinglobal Partnership Firm. Prescription medicines require a valid prescription where applicable. Any regulated pharmaceutical activity is undertaken by the relevant independent provider subject to applicable law. Always consult an appropriately qualified healthcare professional before using or changing any medicine.

Scroll to Top